Polysaccharide microneedles and 3D printing explored for cancer immunotherapy applications
3D Printing Industry
FROM THE ARTICLE
Researchers have reviewed the use of polysaccharide-based microneedles (PMNs) for cancer immunotherapy, examining how additive manufacturing methods, including 3D printing, can support the development of transdermal drug delivery systems. The study, published in Glycoscience & Therapy, focuses…
This story was originally published by 3D Printing Industry.
Read Full Story on 3D Printing IndustryRelated Stories
3D Printing & Prefab3DCP Group Completes 36 3D Printed Student Apartments Below Denmark’s Subsidized Housing Cost Cap3D Printing Industry3D Printing & PrefabHow RMIT Researchers Made 3D Printed Titanium Float on Water3D Printing Industry3D Printing & PrefabUMaine Launches 3Dirigo X: A 3D Printed 30-Foot Boat3D Printing Industry3D Printing & PrefabSRNL and 3D Systems Target Nuclear-Grade Components With New AM Partnership3D Printing Industry